The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients
The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients
复制标题
DOI:
10.1016/s1535-6108(02)00041-7
复制
发表时间:
2002-03-01
期刊:
影响因子:
50.3
通讯作者:
Amon, A
中科院分区:
文献类型:
--
作者:
Elledge, SJ;Amon, A
The tumor suppressor gene BRCA1 is required for the cellular response to DNA damage and homologous recombination, although the exact function it plays in these processes is unclear (Moynahan et al., 1999; Scully and Livingston, 2000). Consistent with the idea that BRCA1 plays a central housekeeping role within cells, mice lacking BRCA1 die very early in embryogenesis (E7. 5 or earlier) due to extreme genomic instability and activation of the p53/p21 pathway (Gowen et al., 1996; Hakem et al., 1996; Ludwig et al., 1997). Despite its apparent central role in double-strand break repair, loss of BRCA1 function appears to affect only a very specific and small subset of tissues in humans. Although a slight increase in predisposition of other cancer types may exist in patients carrying a germline mutation in the BRCA1 gene, a dramatic increase in predisposition is observed only for cancer of the breast and ovary in these individuals (reviewed in Welcsh et al., 1998; Scully and Livingston, 2000; Rosen et al., 2001). Most mutations in BRCA1 thus far represent single base pair deletions, insertions or large genomic rearrangements likely causing a complete loss of function of BRCA1 due to the resulting frameshifts (Neuhausen and Ostrander, 1997; Blackwood and Weber, 1998), excluding the possibility that these BRCA1 mutations are weak hypomorphic alleles. The phenotypes associated with these truncations are in fact expected to be at least as deleterious as the BRCA1 mutations made thus far in mice.